NEU neuren pharmaceuticals limited

Ann: Phase 2 trial shows significant improvements in Angelman, page-87

  1. 13,050 Posts.
    lightbulb Created with Sketch. 788
    Kjt1969/others: Kjt1969: I have had no doubts whatsoever in respect to the effectiveness of NNZ-2591.... But simply 'ignoring' the beaten down share price I do not find to be an 'easy' thing to do. Which kind of share-holder (in her/his right mind) would be selling this stock?? Baffling for certain.
    And: how much lower will the share-price go, I start to wonder?!
    Comments welcome - especially from my two most favourite posters in respect to Neuren's fundamentals, i.e. "hottod" and "Little T".

    All the best to all NEU holders and buyers.

    wasa
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.90
Change
-0.205(1.56%)
Mkt cap ! $1.597B
Open High Low Value Volume
$13.20 $13.36 $12.82 $3.381M 258.8K

Buyers (Bids)

No. Vol. Price($)
15 718 $12.89
 

Sellers (Offers)

Price($) Vol. No.
$12.90 243 6
View Market Depth
Last trade - 15.13pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.